Y. Rolland

535 total citations
15 papers, 175 citations indexed

About

Y. Rolland is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Radiation. According to data from OpenAlex, Y. Rolland has authored 15 papers receiving a total of 175 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Radiation. Recurrent topics in Y. Rolland's work include Advanced Radiotherapy Techniques (7 papers), Radiation Therapy and Dosimetry (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Y. Rolland is often cited by papers focused on Advanced Radiotherapy Techniques (7 papers), Radiation Therapy and Dosimetry (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Y. Rolland collaborates with scholars based in France, United States and Hungary. Y. Rolland's co-authors include Élisabeth Le Rumeur, J. de Certaines, Étienne Garin, P. Bourguet, Éveline Boucher, Jean‐Luc Raoul, Marc Pracht, Julien Edeline, Sophie Laffont and Bruno Clément and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Y. Rolland

15 papers receiving 172 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Y. Rolland France	6	70	55	35	30	28	15	175
Fabian Tollens Germany	11	123 1.8×	25 0.5×	49 1.4×	27 0.9×	45 1.6×	28	234
Maximilian Thormann Germany	8	28 0.4×	40 0.7×	32 0.9×	43 1.4×	24 0.9×	42	207
Jan Pieter Pennings Netherlands	9	63 0.9×	40 0.7×	54 1.5×	60 2.0×	55 2.0×	20	247
Giuseppe V. Toia United States	11	178 2.5×	21 0.4×	30 0.9×	21 0.7×	164 5.9×	30	275
Mitsuru Takami Japan	13	61 0.9×	36 0.7×	39 1.1×	36 1.2×	30 1.1×	67	517
Adeel Sabir United States	8	223 3.2×	44 0.8×	83 2.4×	72 2.4×	113 4.0×	8	296
Katherine Shaffer United States	8	77 1.1×	22 0.4×	39 1.1×	62 2.1×	19 0.7×	10	299
Grzegorz Rosiak Poland	7	33 0.5×	33 0.6×	28 0.8×	35 1.2×	15 0.5×	23	122
Han Lin China	9	53 0.8×	22 0.4×	124 3.5×	98 3.3×	39 1.4×	16	286

Countries citing papers authored by Y. Rolland

Since Specialization

Citations

This map shows the geographic impact of Y. Rolland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Rolland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Rolland more than expected).

Fields of papers citing papers by Y. Rolland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Rolland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Rolland. The network helps show where Y. Rolland may publish in the future.

Co-authorship network of co-authors of Y. Rolland

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Rolland. A scholar is included among the top collaborators of Y. Rolland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Rolland. Y. Rolland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Angioni, Davide, et al.. (2025). Body composition of older adults with normal body mass index. Cross-sectional analysis of the Toulouse Frailty clinic. The Journal of Frailty & Aging. 14(1). 100003–100003. 2 indexed citations

Baère, Thierry de, Marc Pracht, Y. Rolland, et al.. (2021). Results from the phase I dose-escalation study of the radiation enhancer NBTXR3 for the treatment of HCC and liver metastases.. Journal of Clinical Oncology. 39(3_suppl). 319–319. 5 indexed citations

Pracht, Marc, Y. Rolland, Thierry de Baère, et al.. (2020). Treatment of hepatocellular carcinoma and liver metastases with hafnium oxide nanoparticles activated by SBRT: A phase I/II trial.. Journal of Clinical Oncology. 38(4_suppl). 537–537. 1 indexed citations

Baère, Thierry de, Y. Rolland, J.-P. Bronowicki, et al.. (2020). Phase I/II Study Of Radiation Enhancing Hafnium Oxide Nanoparticles NBTXR3 Activated by SBRT in HCC and Liver Metastases Patients. International Journal of Radiation Oncology*Biology*Physics. 108(3). e577–e578. 1 indexed citations

Baère, T. de, Marc Pracht, Y. Rolland, et al.. (2020). PH-0159: NANORAY-103: Phase I/II trial of NBTXR3 activated by SBRT in patients with HCC and liver metastases. Radiotherapy and Oncology. 152. S74–S75. 2 indexed citations

Garin, Étienne, Boris Guiu, Julia Chalaye, et al.. (2020). Major impact of personalized dosimetry using 90Y loaded glass microspheres SIRT in HCC: Final overall survival analysis of a multicenter randomized phase II study (DOSISPHERE-01).. Journal of Clinical Oncology. 38(4_suppl). 516–516. 21 indexed citations

Dicker, Adam P., Thierry de Baère, Caroline Hoffmann, et al.. (2019). Hafnium Oxide Nanoparticles Activated By Radiotherapy: Potential for Local Treatment of a Wide Variety of Solid Tumors. International Journal of Radiation Oncology*Biology*Physics. 105(1). S241–S241. 1 indexed citations

Pracht, Marc, É. Chajon, Y. Rolland, et al.. (2019). Phase I/II trial of NBTXR3 activated by SBRT in patients with hepatocellular carcinoma or liver metastasis. Annals of Oncology. 30. v291–v291. 6 indexed citations

Pracht, Marc, Y. Rolland, Thierry de Baère, et al.. (2019). Hafnium Oxide Nanoparticles Activated by SBRT for the Treatment of Hepatocellular Carcinoma and Liver Metastasis: A Phase I/II Trial. International Journal of Radiation Oncology*Biology*Physics. 105(1). S110–S111. 2 indexed citations

10.

Chajon, É., Marc Pracht, Thierry de Baère, et al.. (2018). A phase I/II trial of hafnium oxide nanoparticles activated by radiotherapy in hepatocellular carcinoma and liver metastasis. Annals of Oncology. 29. v92–v92. 2 indexed citations

11.

Barreto, Philipe de Souto, et al.. (2015). PHYSICAL ACTIVITY AND ß-AMYLOID BRAIN LEVELS IN HUMANS: A SYSTEMATIC REVIEW. The Journal of Prevention of Alzheimer s Disease. 2(1). 1–8. 5 indexed citations

12.

Lenoir, Laurence, Julien Edeline, Y. Rolland, et al.. (2012). Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization. European Journal of Nuclear Medicine and Molecular Imaging. 39(5). 872–880. 28 indexed citations

13.

Garin, Étienne, Sophie Laffont, Y. Rolland, et al.. (2003). Safe radiation exposure of medical personnel by using simple methods of radioprotection while administering 131I-lipiodol therapy for hepatocellular carcinoma. Nuclear Medicine Communications. 24(6). 671–678. 13 indexed citations

14.

Rolland, Y., et al.. (1999). Comparison of automated and visual texture analysis in MRI: Characterization of normal and diseased skeletal muscle. Magnetic Resonance Imaging. 17(9). 1393–1397. 73 indexed citations

15.

Gautier, C., et al.. (1994). [Aspects and value of MRI in the diagnosis and follow-up of common microbes infectious spondylodiscitis. Apropos of 25 clinically and biologically suspected patients].. PubMed. 75(5). 267–77. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact